Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Aug 31, 2025 | (FY)May 31, 2025 | (Q4)May 31, 2025 | (Q3)Feb 28, 2025 | (Q2)Nov 30, 2024 | (Q1)Aug 31, 2024 | (FY)May 31, 2024 | (Q4)May 31, 2024 | (Q3)Feb 29, 2024 | (Q2)Nov 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -237.46%-102.07K | 19.20%-199.92K | -1,231.47%-22.47K | 0.86%-16.86K | -71.05%-130.34K | 80.64%-30.25K | 89.38%-247.42K | 100.55%1.99K | 96.48%-17K | 87.68%-76.2K |
| Net income from continuing operations | -2.51%-167.04K | 9.51%-602.83K | 0.76%-142.03K | 19.46%-142.13K | -0.28%-155.73K | 14.83%-162.94K | 72.65%-666.19K | 66.66%-143.12K | 47.01%-176.46K | 77.87%-155.3K |
| Depreciation and amortization | -99.78%20 | -8.43%33.01K | -33.32%6.01K | -0.13%9K | -0.13%9K | -0.13%9K | 1,019.85%36.05K | 195.67%9.01K | 15,992.86%9.01K | 15,710.53%9.01K |
| Other non cashItems | -46.31%757 | -11.95%4.94K | -63.17%498 | -9.18%1.2K | 34.38%1.84K | -10.53%1.41K | -96.49%5.61K | 136.78%1.35K | --1.32K | --1.37K |
| Change In working capital | -47.51%64.19K | -3.22%364.97K | -16.10%113.05K | -22.83%115.08K | -78.83%14.55K | 398.54%122.29K | 757.10%377.12K | 114.69%134.74K | 148.22%149.13K | -17.44%68.72K |
| -Change in receivables | -44.84%-1.18K | 105.75%138 | 247.59%1.66K | 1,317.96%4.54K | 11.38%-5.25K | -123.82%-814 | -102.73%-2.4K | 106.23%477 | -100.36%-373 | 84.77%-5.92K |
| -Change in prepaid assets | 0.90%-11.87K | -89.26%2.14K | 55.42%5.42K | -40.88%3.06K | 9.22%5.65K | -295.34%-11.98K | 317.70%19.96K | 161.09%3.49K | -42.07%5.17K | -89.77%5.17K |
| -Change in payables and accrued expense | -42.82%77.24K | 0.87%362.68K | -18.96%105.98K | -25.53%107.48K | -79.63%14.15K | 801.80%135.08K | 364.19%359.56K | 71.80%130.78K | 134.10%144.33K | -2.96%69.47K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -237.46%-102.07K | 19.20%-199.92K | -1,231.47%-22.47K | 0.86%-16.86K | -71.05%-130.34K | 80.64%-30.25K | 89.38%-247.42K | 100.55%1.99K | 96.48%-17K | 87.68%-76.2K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 1,947.84%367.31K | -828.24%-1.58K | 97.86K | 2,546.02%241.03K | 404.44%30K | -101.81%-19.88K | -100.09%-170 | 0 | -106.22%-9.85K |
| Net issuance payments of debt | --0 | 45.62%-10.72K | ---1.3K | --0 | -300.00%-39.42K | 404.44%30K | -499.94%-19.71K | --0 | --0 | ---9.85K |
| Net common stock issuance | ---- | --395K | --0 | --100K | ---- | ---- | --0 | --0 | --0 | ---- |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net other financing activities | ---- | -9,881.76%-16.97K | ---277 | ---2.14K | ---- | ---- | 99.62%-170 | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | 1,947.84%367.31K | -828.24%-1.58K | --97.86K | 2,546.02%241.03K | 404.44%30K | -101.81%-19.88K | -100.09%-170 | --0 | -106.22%-9.85K |
| Net cash flow | ||||||||||
| Beginning cash position | 914.03%185.71K | -93.59%18.31K | 1,171.42%209.76K | 284.32%128.76K | -84.89%18.07K | -93.59%18.31K | -81.17%285.61K | -96.41%16.5K | -82.45%33.5K | -81.63%119.56K |
| Current changes in cash | -41,559.59%-102.07K | 162.63%167.4K | -1,424.28%-24.05K | 576.38%81K | 228.62%110.69K | 99.85%-245 | 78.29%-267.29K | 101.04%1.82K | -106.33%-17K | 81.29%-86.06K |
| End cash Position | 362.91%83.64K | 914.03%185.71K | 914.03%185.71K | 1,171.42%209.76K | 284.32%128.76K | -84.89%18.07K | -93.59%18.31K | -93.59%18.31K | -96.41%16.5K | -82.45%33.5K |
| Free cash from | -237.46%-102.07K | 19.20%-199.92K | -1,231.47%-22.47K | 0.86%-16.86K | -71.05%-130.34K | 80.64%-30.25K | 89.38%-247.42K | 100.55%1.99K | 96.48%-17K | 87.68%-76.2K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.